+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Substance Abuse Treatment Market - Global Forecast 2026-2032- Product Image
Substance Abuse Treatment Market - Global Forecast 2026-2032- Product Image
Sale

Substance Abuse Treatment Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5460270
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Substance Abuse Treatment Market is projected to reach USD 13.93 Billion in 2026. It is expected to continue growing at a CAGR of 7.26%, reaching USD 21.32 Billion by 2032.

Substance abuse treatment is moving from episodic detoxification toward integrated, evidence-based care for substance use disorders, including opioid use disorder, alcohol use disorder, stimulant use disorder, and polysubstance use. The market is shaped by rising overdose risk, broader mental health awareness, and demand for medication-assisted treatment, behavioral therapy, harm reduction, and long-term recovery support.

Verified public health data underline the urgency. UNODC reported that 292 million people used drugs in 2022, 64 million lived with drug use disorders, and only about one in eleven people with drug use disorders received treatment. WHO has also linked alcohol consumption to approximately 2.6 million deaths annually and psychoactive drug use to hundreds of thousands of deaths, reinforcing substance abuse treatment as a core healthcare priority.

Transformative Shifts in the Treatment Landscape

The treatment landscape is being reshaped by wider acceptance of medication-assisted treatment, expansion of telehealth, community-based recovery models, and policy support for naloxone access. Care providers are increasingly combining detoxification, residential treatment, outpatient programs, peer support, and co-occurring mental health care to reduce relapse risk and improve continuity.

Major shifts include a move from punitive drug policy toward public health responses, value-based reimbursement, and integrated behavioral health. In the United States, FDA approval of over-the-counter naloxone in 2023 and expanded buprenorphine prescribing flexibility strengthened access, while similar harm reduction and treatment integration efforts are advancing across Europe, Canada, Australia, and parts of Asia-Pacific.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly relevant to substance abuse treatment through risk stratification, relapse prediction, patient engagement, clinical documentation, and population health management. AI-enabled tools can analyze electronic health records, claims data, screening results, and wearable signals to identify patients who may need early intervention or stepped-up support.

The cumulative impact depends on governance. AI can improve referral matching, automate intake workflows, support virtual counseling, and personalize recovery plans, but substance use disorder data require rigorous privacy, bias mitigation, explainability, and clinical oversight under frameworks such as HIPAA, GDPR, and emerging AI safety regulations.

Key Regional Insights: Global Demand and Access

North America remains a highly mature substance abuse treatment region, driven by high opioid use disorder burden, Medicaid and commercial reimbursement, established medication-assisted treatment infrastructure, and strong private provider networks. Europe is advancing through public health systems, the European Union drugs strategy, opioid substitution therapy, and harm reduction models, while the United Kingdom, Germany, France, Italy, and Spain continue to balance treatment access with workforce constraints and regional differences in service delivery.

Asia-Pacific is expanding from a lower treatment penetration base as China, India, Japan, South Korea, and Australia increase investment in mental health, digital health, and community intervention. Latin America, led by Brazil and Mexico, faces rising demand for affordable addiction treatment and public-private service models amid alcohol, stimulant, and opioid-related challenges. The Middle East, especially GCC markets, is building specialized behavioral health capacity and confidentiality-centered care, while Africa has a significant unmet need due to limited trained workforce, stigma, underfunded treatment systems, and constrained access to evidence-based addiction medicine.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are gradually strengthening substance abuse treatment through public health campaigns, rehabilitation capacity, and cross-border drug control cooperation, though treatment access remains uneven across income levels and urban-rural settings. The GCC is investing in behavioral health infrastructure, addiction rehabilitation, and confidentiality-focused care models as mental health policy modernization improves demand visibility and encourages earlier engagement with treatment services.

The European Union benefits from coordinated drug monitoring, harm reduction standards, opioid agonist treatment availability, and publicly funded treatment systems, while BRICS countries represent high-volume demand with diverse regulatory, reimbursement, and public health environments across Brazil, Russia, India, China, and South Africa. G7 countries lead in evidence-based addiction medicine, naloxone access, digital health adoption, and integrated behavioral healthcare, and NATO members increasingly recognize substance use treatment as part of military readiness, veteran health, trauma-informed care, and resilience planning.

Key Country Insights: Priority Markets for Substance Abuse Treatment

The United States faces a severe overdose burden and continues to expand medication-assisted treatment, naloxone access, behavioral health integration, and payer-supported recovery programs, while Canada emphasizes harm reduction, supervised consumption services, safer supply discussions, and opioid agonist therapy. Mexico and Brazil face growing demand for scalable public and private treatment models, with Brazil showing strong need for alcohol and drug rehabilitation capacity and Mexico addressing cross-border drug supply pressures and community-based treatment gaps.

In Europe, the United Kingdom, Germany, France, Italy, and Spain rely on established public health systems but need faster access, workforce expansion, and integrated mental health support; Russia maintains a distinct regulatory approach to opioid substitution therapy, affecting treatment modality availability. China and India offer significant public health relevance through mental health reform, large population needs, and digital care scale, while Japan, Australia, and South Korea are characterized by higher healthcare quality, growing telehealth use, and rising attention to alcohol, stimulant, opioid, and behavioral health comorbidities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-based treatment models that combine medication-assisted treatment, cognitive behavioral therapy, contingency management, peer recovery support, overdose prevention, and coordinated care for co-occurring mental health conditions. Programs should track retention, relapse, overdose reversal, patient-reported outcomes, treatment engagement, and social determinants such as housing, employment, family support, and criminal justice involvement.

Providers and investors should build hybrid care models, partner with payers and public agencies, expand culturally competent care, and strengthen workforce training for addiction medicine, psychiatry, counseling, and peer support. Digital tools should be deployed only with clear clinical validation, privacy safeguards, and measurable improvement in access, adherence, retention, and long-term recovery outcomes.

Research Methodology and Evidence Base

This executive summary is based on triangulation of public health databases, regulatory updates, peer-reviewed addiction medicine literature, and institutional sources including WHO, UNODC, CDC, SAMHSA, FDA, and European drug monitoring authorities. Market interpretation considers treatment access, policy direction, reimbursement, clinical evidence, disease burden, workforce capacity, and regional care infrastructure.

The methodology emphasizes verified, data-backed insights rather than speculative claims. Qualitative assessment was applied to identify growth drivers, unmet needs, adoption barriers, technology impact, and regional differences across substance abuse treatment services, medication-assisted treatment, telehealth, harm reduction, relapse prevention, and recovery support ecosystems.

Conclusion: A Market Defined by Access and Outcomes

The substance abuse treatment market is entering a decisive period as governments, payers, providers, and communities recognize addiction as a chronic, treatable health condition. Demand is supported by high unmet need, overdose prevention priorities, wider use of medication-assisted treatment, and integration with mental healthcare.

Organizations that combine clinical quality, scalable access, digital enablement, and patient-centered recovery support will be best positioned to improve outcomes and support sustainable growth. The strongest strategies will align evidence-based care with regional policy realities, reimbursement incentives, privacy requirements, workforce readiness, and measurable public health impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Substance Abuse Treatment Market, by Treatment Mode
7.1. Introduction
7.2. Day Treatment
7.3. Detoxification
7.3.1. Medical Detox
7.3.2. Non Medical Detox
7.4. Inpatient
7.4.1. Hospital Based Inpatient
7.4.2. Residential Inpatient
7.5. Outpatient
7.5.1. Intensive Outpatient Program
7.5.2. Standard Outpatient Program
7.6. Telehealth
7.6.1. Asynchronous Telehealth
7.6.2. Synchronous Telehealth
8. Substance Abuse Treatment Market, by Substance Type
8.1. Introduction
8.2. Alcohol
8.3. Cannabis
8.4. Opioids
8.5. Stimulants
9. Substance Abuse Treatment Market, by Drug Class
9.1. Introduction
9.2. Opioid Antagonists
9.3. Detoxification Medications
9.4. Anti Craving Medications
10. Substance Abuse Treatment Market, by End User
10.1. Introduction
10.2. Clinic
10.3. Homecare
10.4. Hospitals
10.5. Rehabilitation Centers
11. Substance Abuse Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Online
11.3. Offline
12. Substance Abuse Treatment Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Substance Abuse Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Substance Abuse Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AbbVie Inc.
16.2. Acadia Healthcare Company Inc.
16.3. Alkermes plc
16.4. Amneal Pharmaceuticals Inc.
16.5. AstraZeneca PLC
16.6. Bausch Health Companies Inc.
16.7. BioCorRx Inc.
16.8. Braeburn Inc.
16.9. Camurus AB
16.10. Cipla Limited
16.11. Dr. Reddy's Laboratories Ltd.
16.12. Eli Lilly and Company
16.13. Emergent BioSolutions Inc.
16.14. Glenmark Pharmaceuticals Ltd.
16.15. GSK plc
16.16. Hikma Pharmaceuticals plc
16.17. Indivior PLC
16.18. Lannett Company Inc.
16.19. Lupin Limited
16.20. Mallinckrodt Pharmaceuticals plc
16.21. Novartis AG
16.22. Orexo AB
16.23. Perrigo Company plc
16.24. Pfizer Inc.
16.25. Sanofi S.A.
16.26. Sun Pharmaceutical Industries Ltd.
16.27. Teva Pharmaceutical Industries Ltd.
16.28. Viatris Inc.
16.29. Zydus Lifesciences Limited
List of Figures
FIGURE 1. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DAY TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DAY TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DAY TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DETOXIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DETOXIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DETOXIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MEDICAL DETOX MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MEDICAL DETOX MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MEDICAL DETOX MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL NON MEDICAL DETOX MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL NON MEDICAL DETOX MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL NON MEDICAL DETOX MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL HOSPITAL BASED INPATIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL HOSPITAL BASED INPATIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL HOSPITAL BASED INPATIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL RESIDENTIAL INPATIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL RESIDENTIAL INPATIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL RESIDENTIAL INPATIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL OUTPATIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL OUTPATIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL OUTPATIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL INTENSIVE OUTPATIENT PROGRAM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL INTENSIVE OUTPATIENT PROGRAM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL INTENSIVE OUTPATIENT PROGRAM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL STANDARD OUTPATIENT PROGRAM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL STANDARD OUTPATIENT PROGRAM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL STANDARD OUTPATIENT PROGRAM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL TELEHEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL TELEHEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL TELEHEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ASYNCHRONOUS TELEHEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ASYNCHRONOUS TELEHEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL ASYNCHRONOUS TELEHEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SYNCHRONOUS TELEHEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SYNCHRONOUS TELEHEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SYNCHRONOUS TELEHEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ALCOHOL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ALCOHOL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ALCOHOL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CANNABIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CANNABIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CANNABIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL OPIOIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL STIMULANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL STIMULANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL STIMULANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL OPIOID ANTAGONISTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL OPIOID ANTAGONISTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL OPIOID ANTAGONISTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DETOXIFICATION MEDICATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DETOXIFICATION MEDICATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL DETOXIFICATION MEDICATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ANTI CRAVING MEDICATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ANTI CRAVING MEDICATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ANTI CRAVING MEDICATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CLINIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CLINIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CLINIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HOMECARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HOMECARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HOMECARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 117. EUROPE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. EUROPE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 119. EUROPE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 120. EUROPE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 121. EUROPE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 122. EUROPE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 123. EUROPE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 124. EUROPE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 125. EUROPE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. EUROPE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. MIDDLE EAST SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 137. AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 139. AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 140. AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 141. AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 142. AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 143. AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 144. AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 145. AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 146. AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. ASEAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. ASEAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 150. ASEAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 151. ASEAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 152. ASEAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 153. ASEAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 154. ASEAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 155. ASEAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 156. ASEAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. ASEAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 158. GCC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GCC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 160. GCC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 161. GCC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 162. GCC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 163. GCC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 164. GCC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 165. GCC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 166. GCC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. GCC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 178. BRICS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 179. BRICS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 180. BRICS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 181. BRICS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 182. BRICS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 183. BRICS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 184. BRICS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 185. BRICS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 186. BRICS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. BRICS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 188. G7 SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 189. G7 SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 190. G7 SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 191. G7 SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 192. G7 SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 193. G7 SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 194. G7 SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 195. G7 SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 196. G7 SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. G7 SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 198. NATO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 199. NATO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 200. NATO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 201. NATO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 202. NATO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 203. NATO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 204. NATO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 205. NATO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 206. NATO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 207. NATO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 208. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 210. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 211. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 212. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 213. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 214. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 215. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 216. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 217. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 219. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 220. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 221. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 222. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 223. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 224. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 225. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 226. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 227. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 228. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 229. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 230. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 231. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 232. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 233. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 234. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 235. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 236. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 237. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 239. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 241. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 242. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 243. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 244. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 245. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 246. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 247. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 249. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 250. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 251. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 252. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 253. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 254. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 255. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 256. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 257. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 259. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 261. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 262. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 263. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 264. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 265. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 266. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 267. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 268. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 269. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 270. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 271. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 272. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 273. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 274. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 275. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 276. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 277. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 279. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 281. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 282. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 283. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 284. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 285. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 286. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 287. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 289. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 290. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 291. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 292. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 293. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 294. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 295. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 296. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 297. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 299. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 301. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 302. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 303. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 304. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 305. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 306. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 307. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 309. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 310. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 311. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 312. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 313. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 314. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 315. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 316. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 317. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 319. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 321. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 322. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 323. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 324. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 325. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 326. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 327. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 328. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 329. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 330. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 331. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 332. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 333. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 334. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 335. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 336. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 337. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 338. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 339. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 340. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT MODE, 2017-2032 (USD MILLION)
TABLE 341. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DETOXIFICATION, 2017-2032 (USD MILLION)
TABLE 342. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY INPATIENT, 2017-2032 (USD MILLION)
TABLE 343. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OUTPATIENT, 2017-2032 (USD MILLION)
TABLE 344. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TELEHEALTH, 2017-2032 (USD MILLION)
TABLE 345. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE TYPE, 2017-2032 (USD MILLION)
TABLE 346. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 347. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 348. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TA

Companies Mentioned

  • AbbVie Inc.
  • Acadia Healthcare Company Inc.
  • Alkermes plc
  • Amneal Pharmaceuticals Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • BioCorRx Inc.
  • Braeburn Inc.
  • Camurus AB
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Emergent BioSolutions Inc.
  • Glenmark Pharmaceuticals Ltd.
  • GSK plc
  • Hikma Pharmaceuticals plc
  • Indivior PLC
  • Lannett Company Inc.
  • Lupin Limited
  • Mallinckrodt Pharmaceuticals plc
  • Novartis AG
  • Orexo AB
  • Perrigo Company plc
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.93 Billion
Forecasted Market Value ( USD ) by 2032 $ 21.32 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Substance Abuse Treatment - Global Strategic Business Report - Product Image

Substance Abuse Treatment - Global Strategic Business Report

  • Report
  • 239 Pages
  • Global
From
Substance Abuse and Addiction Treatment Market Report 2026 - Product Image

Substance Abuse and Addiction Treatment Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Substance Abuse Treatment Market: Analysis by Treatment Type; End-use; Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035 - Product Image

Substance Abuse Treatment Market: Analysis by Treatment Type; End-use; Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035

  • Report
  • 260 Pages
  • Global
From
Substance Abuse Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Histology (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma), Treatment Modality, Drug Class - Product Image

Substance Abuse Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Histology (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma), Treatment Modality, Drug Class

  • Report
  • 160 Pages
  • Global
From
Substance Abuse Treatment Market - Forecast from 2026 to 2031 - Product Image

Substance Abuse Treatment Market - Forecast from 2026 to 2031

  • Report
  • 148 Pages
  • Global
From

About the Market

The Drug Addiction Treatment market is focused on providing treatments for individuals suffering from addiction disorders. This includes medications, psychosocial therapies, and other interventions to help individuals manage their addiction and reduce the risk of relapse. Medications used in drug addiction treatment include agonists, antagonists, and partial agonists, which can help reduce cravings and withdrawal symptoms. Psychosocial therapies, such as cognitive-behavioral therapy, can help individuals identify and address the underlying causes of their addiction. Other interventions, such as contingency management and motivational interviewing, can help individuals stay motivated and engaged in their treatment. Companies in the Drug Addiction Treatment market include Alkermes, Orexo, Indivior, and Braeburn Pharmaceuticals. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.